Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Aug;78(2):418–423. doi: 10.1172/JCI112592

Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid.

R Lorenzet, J Niemetz, A J Marcus, M J Broekman
PMCID: PMC423570  PMID: 3090104

Abstract

Platelets induce generation of procoagulant tissue factor activity (TFa) by mononuclear leukocytes, and also enhance the TFa induced by endotoxin. Our present investigation demonstrated that arachidonic acid, which by itself had no effect on mononuclear TFa, greatly enhanced platelet-induced TFa. The effect was concentration dependent for both platelets and arachidonate (1-20 microM); other fatty acids tested were inactive. The enhancing effect of arachidonate was more pronounced if platelets were exposed to aspirin, suggesting lipoxygenase product involvement. Production of 12-hydroxyeicosatetraenoic acid (12-HETE) was demonstrated biochemically in aspirin-treated platelet/arachidonate/mononuclear cell preparations that generated high levels of TFa. The enhancing role of 12-HETE was verified as follows. Addition of platelet-derived or synthetic 12-HETE amplified endotoxin-induced TFa more than threefold. Other lipoxygenase products were inactive. Enhancement of mononuclear cell TFa by 12-HETE represents a newly described biological function for this eicosanoid in cell-cell interactions between platelets and mononuclear cells.

Full text

PDF
419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  2. Crutchley D. J. Effects of inhibitors of arachidonic acid metabolism on thromboplastin activity in human monocytes. Biochem Biophys Res Commun. 1984 Feb 29;119(1):179–184. doi: 10.1016/0006-291x(84)91636-x. [DOI] [PubMed] [Google Scholar]
  3. Edwards R. L., Rickles F. R., Bobrove A. M. Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood. 1979 Aug;54(2):359–370. [PubMed] [Google Scholar]
  4. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  5. Garg S. K., Niemetz J. Tissue factor activity of normal and leukemic cells. Blood. 1973 Nov;42(5):729–735. [PubMed] [Google Scholar]
  6. Goetzl E. J., Woods J. M., Gorman R. R. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. J Clin Invest. 1977 Jan;59(1):179–183. doi: 10.1172/JCI108617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hamberg M., Hamberg G. On the mechanism of the oxygenation of arachidonic acid by human platelet lipoxygenase. Biochem Biophys Res Commun. 1980 Aug 14;95(3):1090–1097. doi: 10.1016/0006-291x(80)91584-3. [DOI] [PubMed] [Google Scholar]
  8. Levy G. A., Edgington T. S. Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med. 1980 May 1;151(5):1232–1244. doi: 10.1084/jem.151.5.1232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Levy G. A., Schwartz B. S., Curtiss L. K., Edgington T. S. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. J Clin Invest. 1981 Jun;67(6):1614–1622. doi: 10.1172/JCI110196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lorenzet R., Peri G., Locati D., Allavena P., Colucci M., Semeraro N., Mantovani A., Donati M. B. Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood. 1983 Aug;62(2):271–273. [PubMed] [Google Scholar]
  11. Marcus A. J., Broekman M. J., Safier L. B., Ullman H. L., Islam N., Sherhan C. N., Rutherford L. E., Korchak H. M., Weissmann G. Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro. Biochem Biophys Res Commun. 1982 Nov 16;109(1):130–137. doi: 10.1016/0006-291x(82)91575-3. [DOI] [PubMed] [Google Scholar]
  12. Marcus A. J., Safier L. B., Ullman H. L., Broekman M. J., Islam N., Oglesby T. D., Gorman R. R. 12S,20-dihydroxyicosatetraenoic acid: a new icosanoid synthesized by neutrophils from 12S-hydroxyicosatetraenoic acid produced by thrombin- or collagen-stimulated platelets. Proc Natl Acad Sci U S A. 1984 Feb;81(3):903–907. doi: 10.1073/pnas.81.3.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Marcus A. J. The eicosanoids in biology and medicine. J Lipid Res. 1984 Dec 15;25(13):1511–1516. [PubMed] [Google Scholar]
  14. Muhlfelder T. W., Niemetz J., Kreutzer D., Beebe D., Ward P. A., Rosenfeld S. I. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation. J Clin Invest. 1979 Jan;63(1):147–150. doi: 10.1172/JCI109269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. NEMERSON Y., SPAET T. H. THE ACTIVATION OF FACTOR X BY EXTRACTS OF RABBIT BRAIN. Blood. 1964 May;23:657–668. [PubMed] [Google Scholar]
  16. Niemetz J., Fani K. Role of leukocytes in blood coagulation and the generalized Shwartzman reaction. Nat New Biol. 1971 Aug 25;232(34):247–248. doi: 10.1038/newbio232247a0. [DOI] [PubMed] [Google Scholar]
  17. Niemetz J., Fani K. Thrombogenic activity of leukocytes. Blood. 1973 Jul;42(1):47–59. [PubMed] [Google Scholar]
  18. Niemetz J., Marcus A. J. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes. J Clin Invest. 1974 Dec;54(6):1437–1443. doi: 10.1172/JCI107891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Osterud B., Bjørklid E. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin. Scand J Haematol. 1982 Aug;29(2):175–184. doi: 10.1111/j.1600-0609.1982.tb00580.x. [DOI] [PubMed] [Google Scholar]
  20. Osterud B., Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost. 1983 Feb 28;49(1):5–7. [PubMed] [Google Scholar]
  21. Pinder P. B., Hunt J. A., Zacharski L. R. In vitro stimulation of monocyte tissue factor activity by autologous platelets. Am J Hematol. 1985 Aug;19(4):317–325. doi: 10.1002/ajh.2830190402. [DOI] [PubMed] [Google Scholar]
  22. Piper P. J. Pharmacology of leukotrienes. Br Med Bull. 1983 Jul;39(3):255–259. doi: 10.1093/oxfordjournals.bmb.a071829. [DOI] [PubMed] [Google Scholar]
  23. Prydz H., Lyberg T. Effect of some drugs on thromboplastin (factor III) activity of human monocytes in vitro. Biochem Pharmacol. 1980 Jan 1;29(1):9–14. doi: 10.1016/0006-2952(80)90236-1. [DOI] [PubMed] [Google Scholar]
  24. Rivers R. P., Hathaway W. E., Weston W. L. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol. 1975 Jul;30(3):311–316. doi: 10.1111/j.1365-2141.1975.tb00547.x. [DOI] [PubMed] [Google Scholar]
  25. Rothberger H., Zimmerman T. S., Vaughan J. H. Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes. J Clin Invest. 1978 Sep;62(3):649–655. doi: 10.1172/JCI109172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983 May 6;220(4597):568–575. doi: 10.1126/science.6301011. [DOI] [PubMed] [Google Scholar]
  27. Schwartz B. S., Levy G. A., Curtiss L. K., Fair D. S., Edgington T. S. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest. 1981 Jun;67(6):1650–1658. doi: 10.1172/JCI110201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sitrin R. G., Kaltreider H. B., Goldyne M. E. Prostaglandin E is required for the augmentation of procoagulant activity of LPS-stimulated rabbit alveolar macrophages. J Immunol. 1984 Feb;132(2):867–871. [PubMed] [Google Scholar]
  29. Smariga P. E., Maynard J. R. Purification of a platelet protein which stimulates fibrinolytic inhibition and tissue factor in human fibroblasts. J Biol Chem. 1982 Oct 25;257(20):11960–11965. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES